Nab-paclitaxel + Gemcitabine trials for Pancreatic cancer

All Nab-paclitaxel + Gemcitabine trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying Nab-paclitaxel + Gemcitabine for Pancreatic cancer

• 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
  NCT07043270 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
  NCT05969171 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer
  NCT07701486 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer
  NCT07238283 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
  NCT05218889 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Nab-paclitaxel + Gemcitabine for Pancreatic cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.